Shortage of EpiPens to treat severe allergic reactions has consumers concerned
Pfizer, the drug company that produces the EpiPen, announced last week with Health Canada that there was limited inventory of both the adult 0.30-mg device and the children's 0.15-mg epinephrine auto-injectors. The notice marked the sixth time since the beginning of 2017 that there's been a shortfall in supply of EpiPens
